FindTrial
Sign In

The renoprotective effect of calcium channel blocker

The renoprotective effect of calcium channel blocker on metabolic syndrome patients: a nationwide population based approach

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006811
Enrollment
100000
Registered
2021-12-07
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Yonsei University Wonju College of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: people who received a national health examination between 2009 and 2012 and aged between 19 and 90

Exclusion criteria

Exclusion criteria: patients who did not received a national health examination aged below 19 years or above 90 years

Design outcomes

Primary

MeasureTime frame
devlopment of chronic kidney disease—

Secondary

MeasureTime frame
received renal replacement therapy—

Countries

Korea, Republic of

Contacts

Public ContactJun young Lee

Yonsei University Wonju College of Medicine

junyoung07@yonsei.ac.kr+82-33-741-0935

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026